CVN058

· Cerevance Alpha, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CVN058, covering 2024-10-04 to 2024-10-04. Get the full timeline:

Most recent: Clinical Trial Update: CVN058 Effect on Mismatch Negativity in Schizophrenics [Phase 1]